Artificial Intelligence (AI)-Generated Personalized Medical Reminder Global Market Report 2025

The artificial intelligence (AI)-generated personalized medical reminder market size has grown exponentially in recent years. It will grow from $1.35 billion in 2024 to $1.65 billion in 2025 at a compound annual growth rate (CAGR) of 22.4%. Growth during the historic period can be attributed to the rising adoption of digital health platforms, growing emphasis on medication adherence, increasing use of AI in healthcare management, expanding smartphone penetration, and greater utilization of wearable health devices.

The artificial intelligence (AI)-generated personalized medical reminder market size is expected to see exponential growth in the next few years. It will grow to $3.65 billion in 2029 at a compound annual growth rate (CAGR) of 22%. Growth during the forecast period can be attributed to the increasing demand for personalized healthcare solutions, rising adoption of AI-driven health assistants, growing investment in digital therapeutics, expanding use of cloud-based medical reminder systems, and increasing awareness of preventive healthcare. Key trends in the forecast period include advancements in AI-based natural language processing, innovations in predictive health analytics, development of context-aware reminder systems, research and development in personalized digital therapeutics, and progress in remote patient monitoring technologies.

The increasing prevalence of non-communicable diseases (NCDs) is expected to drive the growth of the artificial intelligence (AI)-generated personalized medical reminder market in the coming years. Non-communicable diseases are long-term medical conditions that are not caused by infections and cannot be transmitted between individuals. The surge in NCDs is primarily due to sedentary lifestyles, as reduced physical activity over time affects the body’s ability to regulate weight, blood pressure, and metabolism, resulting in chronic health complications. AI-generated personalized medical reminders assist in managing NCDs by providing timely alerts for medication, lifestyle modifications, and follow-up care, which enhances adherence to treatment plans and improves long-term health outcomes. For instance, according to the World Health Organization (WHO) in February 2024, global cancer cases are projected to exceed 35 million by 2050, marking a 77% increase from the estimated 20 million cases in 2022. Therefore, the growing burden of non-communicable diseases is a key factor driving the expansion of the AI-generated personalized medical reminder market.

Major companies in the market are increasingly developing voice-based technologies, such as AI-driven voice assistants, to improve medication reminders and patient engagement. These assistants utilize artificial intelligence to recognize, interpret, and respond to spoken commands, enabling real-time, hands-free interactions that provide personalized reminders, guidance, and support for effective health management. For example, in April 2025, Medisafe International, a US-based medical device company, launched the Voice Intelligent Agent (VIA), an AI-powered voice assistant designed to address the pharmaceutical industry’s $5 billion patient support gap. This technology helps specialty brands engage and retain patients through intelligent, personalized interactions, significantly improving adherence and patient support across treatment journeys.

In September 2025, Innovaccer, a US-based health data analytics company, acquired Story Health for an undisclosed amount to strengthen its AI-driven care platform. The integration of Story Health’s virtual specialty care capabilities is intended to enhance patient engagement, improve medication adherence, and expand the use of personalized medical reminders. Story Health, also based in the US, provides AI-generated personalized medical reminders that support patients in maintaining consistent medication schedules. This acquisition reinforces Innovaccer’s position in offering advanced, patient-centered AI healthcare solutions.

Major players in the artificial intelligence (ai)-generated personalized medical reminder market are Google LLC, Microsoft Corporation, Oracle Corporation, Philips Healthcare, Otsuka Holdings Co. Ltd., Garmin Ltd., Teladoc Health Inc., Veradigm LLC, Tempus AI Inc., Merative LLC, MedMinder Systems Inc., MedAdvisor Ltd., Artera Services LLC, Medisafe Inc., AdhereTech Inc., CarePredict Inc., AiCure Inc., WatchMinder Company, Pivotell Ltd., and CareClinic.

North America was the largest region in the artificial intelligence (AI)-generated personalized medical reminder market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI)-generated personalized medical reminder report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The artificial intelligence (AI)-generated personalized medical reminder market research report is one of a series of new reports that provides artificial intelligence (AI)-generated personalized medical reminder market statistics, including artificial intelligence (AI)-generated personalized medical reminder industry global market size, regional shares, competitors with an artificial intelligence (AI)-generated personalized medical reminder market share, detailed artificial intelligence (AI)-generated personalized medical reminder market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-generated personalized medical reminder industry. The artificial intelligence (AI)-generated personalized medical reminder market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Artificial intelligence (AI) generated personalized medical reminders are digital solutions designed to create tailored reminders for medical routines and medication schedules. These systems utilize AI algorithms to analyze individual health patterns and determine optimal notification times. The AI-generated personalized medical reminder system promotes adherence and reduces missed doses through intelligent, real-time guidance, while also improving consistency in health management and lessening the cognitive effort required from users.

The primary components of artificial intelligence (AI) generated personalized medical reminders include software, hardware, and services. Software consists of AI-powered platforms and applications that automate, customize, and manage medical reminders to enhance patient compliance and engagement. Deployment modes include cloud-based and on-premises systems, which are applied in areas such as medication adherence, chronic disease management, elderly care, remote patient monitoring, and other uses. The main end users include hospitals and clinics, home care providers, pharmacies, individuals, and others.

The countries covered in the artificial intelligence (AI)-generated personalized medical reminder market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI)-generated personalized medical reminder market consists of revenues earned by entities by providing services such as personalized reminder scheduling, adherence tracking, intelligent alert optimization, and data-driven insights. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-generated personalized medical reminder market also includes sales of smart pill bottles, wearable devices, smart pill dispensers, mobile health kits, smart pill caps, biometric sensors, tablets, smartphones, connected medical devices, and smartwatches. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.